VERA

39.96

2.94% -1.21

Handel nachbörslich: 39.96

Vera Therapeutics Inc (VERA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$41.17

Offen:

$41.76

24-Stunden-Volumen:

1.45M

Relative Volume:

1.21

Marktkapitalisierung:

$2.85B

Einnahmen:

Nettoeinkommen (Verlust:

$-299.62M

KGV:

-8.5679

EPS:

-4.6639

Netto-Cashflow:

$-241.73M

1W Leistung:

+2.28%

1M Leistung:

-5.35%

6M Leistung:

+68.11%

1J Leistung:

+44.47%

1-Tages-Spanne:

$38.89

$42.73

1-Wochen-Bereich:

$38.00

$45.38

52-Wochen-Spanne:

$18.53

$56.05

Vera Therapeutics Inc Stock (VERA) Company Profile

Firmenname

Vera Therapeutics Inc

Sektor

Healthcare (1116)

Branche

Biotechnology (621)

Telefon

650-770-0077

Adresse

2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE

Mitarbeiter

249

Twitter

Nächster Verdiensttermin

2024-08-08

Neueste SEC-Einreichungen

VERA's Discussions on Twitter

Compare VERA vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VERA Vera Therapeutics Inc	39.96	2.94B	0	-299.62M	-241.73M	-4.6639
VRTX Vertex Pharmaceuticals Inc	469.34	121.46B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	745.77	78.93B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.45	43.87B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.41	42.07B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	284.05	31.65B	5.36B	287.73M	924.18M	2.5229

Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-16	Eingeleitet	BofA Securities	Buy
2025-08-04	Herabstufung	Wolfe Research	Outperform → Peer Perform
2025-05-05	Fortgesetzt	H.C. Wainwright	Buy
2025-02-04	Eingeleitet	Wolfe Research	Outperform
2025-01-28	Eingeleitet	Goldman	Buy
2024-11-21	Eingeleitet	Wells Fargo	Overweight
2024-10-16	Eingeleitet	Scotiabank	Sector Outperform
2024-01-25	Eingeleitet	Oppenheimer	Outperform
2024-01-08	Eingeleitet	Cantor Fitzgerald	Overweight
2023-12-18	Eingeleitet	Raymond James	Outperform
2023-11-10	Hochstufung	Jefferies	Hold → Buy
2023-08-16	Eingeleitet	Guggenheim	Buy
2023-01-04	Herabstufung	Jefferies	Buy → Hold
2023-01-04	Herabstufung	Wedbush	Outperform → Neutral
2022-07-12	Eingeleitet	JP Morgan	Overweight
2022-05-02	Eingeleitet	H.C. Wainwright	Buy
2022-04-19	Eingeleitet	Wedbush	Outperform

Alle ansehen

Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten

11:06 AM

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - The Motley Fool

11:06 AM

10:36 AM

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - The Motley Fool

10:36 AM

Mar 12, 2026

Aug Big Picture: What is the cash position of Vera Therapeutics Inc2026 Price Action Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn

Mar 12, 2026

Vera Therapeutics urges expanded innovation in global kidney health on World Kidney Day - Traders Union

Mar 12, 2026

Mar 11, 2026

Quarterly Trades: Can Vera Therapeutics Inc deliver consistent EPS growth2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn

Mar 11, 2026

Vera Therapeutics (NASDAQ:VERA) Upgraded to Outperform at Wolfe Research - MarketBeat

Mar 11, 2026

Mar 10, 2026

How (VERA) Movements Inform Risk Allocation Models - Stock Traders Daily

Mar 10, 2026

Wolfe Research upgrades Vera Therapeutics stock rating on valuation By Investing.com - Investing.com Canada

Mar 10, 2026

Vera Therapeutics (NASDAQ:VERA) Trading Up 10.2%What's Next? - MarketBeat

Mar 10, 2026

Vera Therapeutics’ Atacicept Gains FDA Priority, Stock Soars - StocksToTrade

Mar 10, 2026

Mar 09, 2026

Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities - Investing.com Canada

Mar 09, 2026

Vera Therapeutics Adds Christopher Hite to Board - TipRanks

Mar 09, 2026

Mar 08, 2026

Vera Therapeutics Appoints New Board Member - Intellectia AI

Mar 08, 2026

Mar 07, 2026

Can Vera Therapeutics Inc. stock deliver surprise earnings beat2026 EndofYear Setup & Weekly Return Optimization Plans - Naître et grandir

Mar 07, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sahm

Mar 07, 2026

Mar 06, 2026

Six new Vera Therapeutics hires receive 4-year stock awards - Stock Titan

Mar 06, 2026

Vanguard Group Inc. Has $92.72 Million Position in Vera Therapeutics, Inc. $VERA - MarketBeat

Mar 06, 2026

Vera Therapeutics Appoints Christopher Hite to Board of Directors - Sahm

Mar 06, 2026

Vera Therapeutics adds Christopher Hite to board of directors By Investing.com - Investing.com Canada

Mar 06, 2026

Mar 05, 2026

Vera Therapeutics adds Christopher Hite to board of directors - Investing.com

Mar 05, 2026

Vera Therapeutics appoints Christopher Hite to board of directors - marketscreener.com

Mar 05, 2026

Vera Therapeutics Appoints Christopher Hite To Board Of Directors - TradingView

Mar 05, 2026

Royalty Pharma vice chair joins Vera board before potential IgA drug launch - Stock Titan

Mar 05, 2026

Q1 EPS Estimates for Vera Therapeutics Cut by HC Wainwright - MarketBeat

Mar 05, 2026

Mar 03, 2026

Vera Therapeutics Files BLA for Atacicept in IgAN, Target Action Date July 7, 2026 - Intellectia AI

Mar 03, 2026